peptide-solutions
Cathelicidin-derived antimicrobial peptide (10 mg per vial)
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.

LL-37 is the C-terminal 37-residue fragment of human cathelicidin (hCAP18). Research highlights its broad-spectrum antimicrobial activity, immunomodulatory effects, and roles in wound healing and angiogenesis.
Compound Specifications
Select the amount contained in each vial.
Choose one vial, or choose a kit with 10 units priced as 8.
Amount per vial: 10mg
Scientific Documentation
Detailed research information, pharmacological profile, and handling specifications
Disrupts microbial membranes via amphipathic alpha-helix interactions. Modulates innate immune signaling (TLR/NF-κB axis), neutrophil chemotaxis, and angiogenic pathways.
Verified Buyer Reviews
Loading reviews...
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Other research peptides you may be interested in

Body protective compound for tissue repair research
from $95

Immune-modulating peptide for immunology research
from $75

Anti-inflammatory tripeptide for gut health research
from $55